Viewing Study NCT00349193


Ignite Creation Date: 2025-12-25 @ 1:23 AM
Ignite Modification Date: 2026-01-03 @ 6:47 PM
Study NCT ID: NCT00349193
Status: COMPLETED
Last Update Posted: 2011-04-08
First Post: 2006-06-26
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Evaluate the Effectiveness, Tolerability and Safety of Laquinimod
Sponsor: Teva Branded Pharmaceutical Products R&D, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Relapsing Remitting Multiple Sclerosis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Relapsing Remitting Multiple Sclerosis View